FDA.reportPublic FDA data

RELEVIUM LABS, INCORPORATED

Matched from indexed company URL: Relevium Labs, Inc.

FDA Registration(s)#

Registration, FEI, Name table
RegistrationFEINameStatusInitial importerExpiration yearAddress
30126970623012697062RELEVIUM LABS, INCORPORATED1N2026-01-014663 Katie Ln Oxford OH US 45056

GUDID Contact Samples#

Sampled from matched GUDID device records for this company; this is not an exhaustive company contact directory.

Source GUDID, Product, Phone table
Source GUDIDProductPhoneEmail
00860000860000Yarlap I - The Yarlap® device is intended to provide electrical stimulation and neuromuscular re-education for the purpose of rehabilitation of weak pelvic floor muscles for the treatment of stress, urge and mixed urinary incontinence in women and to maintain urinary continence in women.6145687000b.reider@releviumlabs.com
00860000860031Yarlap II - The Yarlap® device is intended to provide electrical stimulation and neuromuscular re-education for the purpose of rehabilitation of weak pelvic floor muscles for the treatment of stress, urge and mixed urinary incontinence in women and to maintain urinary continence in women.6145687000b.reider@releviumlabs.com

Registered Device Listings#

Registration key, Listing key, Premarket submission table
Registration keyListing keyPremarket submissionDeviceProduct codeDecision date
1960172014240508K160773Yarlap IIKPI2016-05-04
1960171621015771K141643YARLAPKPI2015-04-24

Product Codes Associated With Registrations#

Product code, Registration listing records, Latest decision table
Product codeRegistration listing recordsLatest decision
KPI22016-05-04

GUDID#